home / stock / celz / celz news


CELZ News and Press, Creative Medical Technology Holdings Inc. From 06/09/23

Stock Information

Company Name: Creative Medical Technology Holdings Inc.
Stock Symbol: CELZ
Market: OTC
Website: creativemedicaltechnology.com

Menu

CELZ CELZ Quote CELZ Short CELZ News CELZ Articles CELZ Message Board
Get CELZ Alerts

News, Short Squeeze, Breakout and More Instantly...

CELZ - Creative Medical Technology Holdings announces reverse stock split to regain compliance

2023-06-09 14:45:02 ET Creative Medical Technology Holdings ( NASDAQ: CELZ ) has announced a reverse stock split of its common shares at a ratio of 1 for 10, effective at 9:00 a.m. ET on June 12, 2023. The reverse stock split will increase the market price per share of its com...

CELZ - Creative Medical Technology Holdings Announces Reverse Stock Split

Creative Medical Technology Holdings Announces Reverse Stock Split PR Newswire PHOENIX , June 9, 2023 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ) , a biotechnology company focused ...

CELZ - Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform

Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform PR Newswire PHOENIX , May 31, 2023 /PRNewswi...

CELZ - The Emerging Opportunity Dawning in Men's Health Stocks (PFE, MGRX, TDOC, CELZ, HIMS, PTPI, GDRX, AMWL)

2023-05-25 07:18:49 ET The men’s health market is more interesting than you think. The space is characterized by rapid growth and increasing relevance, as men and couples start […] For further details see: The Emerging Opportunity Dawning in Men’s Health Stocks (PFE...

CELZ - Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development

Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development PR Newswire Advancements May Result in Ability to Treat a Broader Patient Population with Immune Disorders PHOENIX , May 22, 2023 /PRNewswire/...

CELZ - Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem(TM) Allogenic Cell Line

Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line PR Newswire Study Demonstrated Significant Efficacy and No Serious Adverse Events ...

CELZ - Erectile Dysfunction Swells as Growth Market for Investors (PFE, MGRX, LLY, CELZ, HIMS, TEVA, BAYRY)

2023-05-12 07:25:46 ET The erectile dysfunction market is expected to grow at a CAGR of 7.1% from 2021 to 2028. The growth of the market is attributed to […] For further details see: Erectile Dysfunction Swells as Growth Market for Investors (PFE, MGRX, LLY, CELZ, HIMS, TEVA, BAYRY)

CELZ - 3 Methods for Finding Penny Stocks to Buy and Hold

2023-04-13 06:00:00 ET Long Term Penny Stocks: Identifying Companies With Long Term Prospects Penny stocks can offer investors an exciting opportunity to uncover hidden gems with substantial long-term growth potential. Though often considered a high-risk, short-term investment, there ar...

CELZ - Biotech Up Massively On Follow-Up Data

2023-04-12 15:24:23 ET A Phoenix-based %Biotech company put on quite a show on Wednesday as shares experienced quite a bit of volatility on what appears to be the third-most actively traded day for the stock in the last year. Shares of %CreativeMedicalTechnologyHoldings (Nasdaq:...

CELZ - Creative Medical surges ~150% after diabetes therapy CELZ-001 shows promise in trial

2023-04-12 09:14:56 ET Creative Medical Technology ( NASDAQ: CELZ ) stock soared ~150% premarket on Wednesday after the company said that one-year follow-up data confirmed significant efficacy and no serious adverse effects in patients using CELZ-001 to treat Type 2 Diabetes. ...

Previous 10 Next 10